Clinical Trials Logo

Clinical Trial Summary

The investigators will conduct a Randomized Controlled Trial (RCT) comparing the Remote Motivational Enhancement (RME) coaching sessions + CHAMindWell screenings arm to an Information-only + CHAMindWell screenings arm on early engagement in treatment support services, as measured by overall action plan initiation.

Clinical Trial Description

In an effort to assess and address patients' mental health needs, Cambridge Health Alliance (CHA) MindWell has been using electronic computerized adaptive testing (CAT-MH) for mental health and social determinants of health (SDOH). This automated screening with adaptive testing helps to identify those who need social services support (e.g. housing, legal, immigration, financial, food, transportation, etc.) or need further comprehensive mental health evaluation and treatment. RME sessions are based on motivational interviewing (MI), which is a collaborative, goal-oriented style of communication designed to resolve ambivalence and strengthen intrinsic motivation for a person's commitment to behavior change by eliciting their own reasons for change in an environment of acceptance and compassion. It is an evidence-based and standardized approach that has demonstrated consistently positive clinical outcomes for engagement in wellness, healthcare, and addiction treatment, including effectively improving medical regimen adherence. In this study, we propose to implement RME sessions to enhance engagement among Bicycle Health patients prescribed Buprenorphine/Naloxone (B/N) who have been assessed using the CAT-MH. This intervention seeks to reduce overdose, enhance B/N treatment retention, and help participants achieve behavior change goals related to their individual SDOH needs, mental health symptoms, and/or wellness in OUD recovery goals. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05184907
Study type Interventional
Source Cambridge Health Alliance
Contact Cassandra Harding, MPH
Phone 617-806-8730
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date February 1, 2022
Completion date September 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05037682 - Pain and Opioid Management in Older Adults N/A
Completed NCT02440256 - Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial N/A
Completed NCT02559973 - Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder Phase 1
Completed NCT02593474 - Medication-Assisted Treatment for Youth With Substance Use Disorders Phase 1
Recruiting NCT05180487 - Parenting Young Children Study N/A
Suspended NCT04577144 - An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery-Long Term
Completed NCT03033732 - A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse Phase 4
Recruiting NCT05086835 - A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders N/A
Recruiting NCT03821337 - Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning N/A
Recruiting NCT05027919 - Assessing a Clinically-meaningful Opioid Withdrawal Phenotype Phase 2
Recruiting NCT05062577 - A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder Phase 2
Recruiting NCT05143424 - Evaluation of the Interactions of Cannabidiol (CBD) With Morphine Phase 1
Recruiting NCT04375033 - A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder Phase 4
Recruiting NCT04916600 - NET Device for Treating Opioid Use Disorder N/A
Completed NCT02942199 - MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE) N/A
Completed NCT02672111 - Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder Phase 3
Completed NCT02044094 - Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder Phase 2
Completed NCT02765867 - Single-dose, Study of RBP-6000 in Opioid Dependent Individuals Phase 1
Completed NCT05127707 - Strategies to Reduce Addiction Stigma Among Health Professionals N/A
Recruiting NCT04567784 - Neuroimaging and CBD for Heroin Use Disorder Phase 2